SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-15-004190
Filing Date
2015-04-30
Accepted
2015-04-30 13:17:55
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2224430z10-q.htm 10-Q 432053
2 EX-31.1 a2224430zex-31_1.htm EX-31.1 15007
3 EX-32.1 a2224430zex-32_1.htm EX-32.1 7495
10 G556913.JPG g556913.jpg GRAPHIC 12554
  Complete submission text file 0001047469-15-004190.txt   4029985

Data Files

Seq Description Document Type Size
4 EX-101.INS nutr-20150331.xml EX-101.INS 680087
5 EX-101.SCH nutr-20150331.xsd EX-101.SCH 23439
6 EX-101.CAL nutr-20150331_cal.xml EX-101.CAL 50877
7 EX-101.DEF nutr-20150331_def.xml EX-101.DEF 56210
8 EX-101.LAB nutr-20150331_lab.xml EX-101.LAB 257117
9 EX-101.PRE nutr-20150331_pre.xml EX-101.PRE 160825
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 15816912
SIC: 2833 Medicinal Chemicals & Botanical Products